TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response June 17, 1988
TCL Archive Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older June 25, 2010
TCL Archive New RFAs Released: Kaposi Sarcoma; Rare Tumors; Biochemical Epidemiology; Dietary Questionnaire; Role of Nicotine August 20, 1982
